Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2215
Nomenclature: serine/threonine kinase 17b
Abbreviated Name: DRAK2
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 372 | 2q32.3 | STK17B | serine/threonine kinase 17b | |
Mouse | - | 372 | 1 C1.1 | Stk17b | serine/threonine kinase 17b (apoptosis-inducing) | |
Rat | - | 371 | 9q31 | Stk17b | serine/threonine kinase 17b |
Previous and Unofficial Names |
DAP kinase-related apoptosis-inducing protein kinase 2 | death-associated protein kinase-related 2 |
Database Links | |
Alphafold | O94768 (Hs), Q8BG48 (Mm), Q91XS8 (Rn) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL3980 (Hs) |
Ensembl Gene | ENSG00000081320 (Hs), ENSMUSG00000026094 (Mm), ENSRNOG00000012502 (Rn) |
Entrez Gene | 9262 (Hs), 98267 (Mm), 170904 (Rn) |
Human Protein Atlas | ENSG00000081320 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:9262 (Hs), mmu:98267 (Mm), rno:170904 (Rn) |
OMIM | 604727 (Hs) |
Pharos | O94768 (Hs) |
RefSeq Nucleotide | NM_004226 (Hs), NM_133810 (Mm), NM_133392 (Rn) |
RefSeq Protein | NP_004217 (Hs), NP_598571 (Mm), NP_596883 (Rn) |
UniProtKB | O94768 (Hs), Q8BG48 (Mm), Q91XS8 (Rn) |
Wikipedia | STK17B (Hs) |
Selected 3D Structures | |||||||||||||
|
|||||||||||||
|
Enzyme Reaction | ||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: DRAK2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
Death-associated kinase (DAPK) family: serine/threonine kinase 17b. Last modified on 26/03/2013. Accessed on 18/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2215.